Colitis after checkpoint blockade: A retrospective cohort study of melanoma patients requiring admission for symptom control-Reference-Cited by-同舟云学术

Colitis after checkpoint blockade: A retrospective cohort study of melanoma patients requiring admission for symptom control

Published:2019-07-09 Issue:11 Volume:8 Page:4986-4999
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Hughes Michael S.¹²^ORCID,Zheng Hui¹²,Zubiri Leyre¹²,Molina Gabriel E.¹²^ORCID,Chen Steven T.¹²³,Mooradian Meghan J.¹²⁴^ORCID,Allen Ian M.¹²,Reynolds Kerry L.¹²⁴,Dougan Michael¹²⁵

Affiliation:

1. Harvard Medical School Boston Massachusetts

2. Department of Medicine Massachusetts General Hospital Boston Massachusetts

3. Department of Dermatology Massachusetts General Hospital Boston Massachusetts

4. Massachusetts General Hospital Cancer Center Boston Massachusetts

5. Division of Gastroenterology Massachusetts General Hospital Boston Massachusetts

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2397

Reference51 articles.

1. Checkpoint Blockade Toxicity and Immune Homeostasis in the Gastrointestinal Tract

2. Coinhibitory Pathways in Immunotherapy for Cancer

3. PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

4. Recent developments and future challenges in immune checkpoint inhibitory cancer treatment

5. Immune checkpoint inhibitors: a patent review (2010-2015)

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing Precision in Detecting Severe Immune-Related Adverse Events: Comparative Analysis of Large Language Models and International Classification of Disease Codes in Patient Records;Journal of Clinical Oncology;2024-09-03

2. Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH–AEG–SEPD–SEOM–GETECCU;Gastroenterología y Hepatología;2024-04

3. Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy;Journal for ImmunoTherapy of Cancer;2024-04

4. Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH–AEG–SEPD–SEOM–GETECCU;Gastroenterología y Hepatología (English Edition);2024-04

5. Updates in the pathogenesis and management of immune-related enterocolitis, hepatitis and cardiovascular toxicities;Immuno-Oncology and Technology;2024-03